Resolve Surgical Technologies
Megan Dean Osorio has a rich work experience spanning over two decades. Megan Dean currently holds the position of President & CEO at Resolve Surgical Technologies since January 2022. Before this, they worked at RTI Surgical as President, Metals from October 2021 to January 2022, and as General Manager, Metals from December 2020 to October 2021. Prior to their role in RTI Surgical, they served as Vice President Marketing from August 2020 to December 2020.
From 2014 to 2020, Megan held various positions at Bioventus, including Vice President, Marketing, Surgical from January 2015 to August 2020, and Global Director, New Products & Analytics from June 2014 to January 2015.
Their career also includes working at Teleflex Medical as Director of Marketing, Surgical (North America & Global) from May 2010 to May 2014. Before that, they held the position of US Group Product Director at Johnson & Johnson from November 2007 to May 2010.
Earlier in their career, Megan worked at Johnson & Johnson - Ethicon as a Product Director from November 2003 to 2007, and at Ethicon, Inc. as an International Market Development Manager from November 2001 to October 2003. Megan Dean started their career at Johnson & Johnson as a Sales Representative / International Market Development Manager in January 2001 and worked there until November 2001.
Megan Dean Osorio holds an MBA degree in Global Marketing from Thunderbird School of Global Management. Prior to that, they completed their BA degree in International Studies at Emory University. No specific start or end years have been provided for either education.
This person is not in any offices
Resolve Surgical Technologies
The story of Resolve Surgical Technologies begins in 1992, when we entered into the industry as Pioneer Surgical Technology, Inc. Shortly thereafter, In 1993, Pioneer launched its first full system of instruments and implants for a major orthopedic OEM partner. This system, along with many other systems that Pioneer had launched, are still regarded as best in class by surgeons and partners. Throughout the years, Pioneer had established itself as a major innovator across the orthopedic community. Then, in 2013, RTI Biologics acquired Pioneer Surgical Technology, Inc. to create RTI Surgical. Both companies saw great success as they worked together to expand both Tissue & Biologics and Metals platforms. In 2020, Montagu Private Equity LLP acquired RTI Surgical’s OEM business. In 2022, due to rapid growth and high industry demand of both divisions, the RTI Surgical Metals division spun off to become Resolve Surgical Technologies.